相关实验视频
Updated: Jun 28, 2025

08:18
A Model of Chronic Nutrient Infusion in the Rat
Published on: August 14, 2013
12.7K
暴露于长期高葡萄糖的INS1细胞中的Glis3的下调有助于与葡萄糖毒性相关的β细胞功能障碍
LilyAnne M Grieve1, Abhya Rani1, Gary T ZeRuth1
1Department of Biological Sciences, Murray State University, Murray, KY, USA.
Islets
|April 23, 2024
概括
Glis3 (Glis家族指3) 对于胰腺β细胞功能至关重要. 由于高葡萄糖和氧化压力的下调,会损害胰岛素的产生和β细胞的身份,从而导致2型糖尿病.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 长期高葡萄糖水平会损害胰腺β细胞,导致功能障碍,胰岛素的产生减少,以及细胞身份的丧失.
- 众所周知,克鲁佩尔样转录因子Glis3 (Glis家族指3) 调节胰岛素转录,其突变与2型糖尿病有关.
研究的目的:
- 为了研究Glis3在胰腺β细胞对高葡萄糖的反应中的作用.
- 阐明Glis3调节胰岛素和β细胞身份的机制.
主要方法:
- 在高葡萄糖条件下,在INS1 832/13细胞中对Glis3的转录分析.
- 在CRISPR/Cas9中介的Glis3.3中断.
- 染色体重塑和促进剂活性测试.
- 分析Glis3和MafA的表达和相互作用.
主要成果:
- 由于高葡萄糖,Glis3的表达迅速下调,部分原因是氧化应激.
- Glis3对于维持胰岛素和MafA表达和防止β细胞不允许基因的上调是必不可少的.
- 在胰岛素促进因子中,Glis3起到先驱性作用,为Pdx1和MafA等转录因子提供更容易的访问.
- Glis3积极调节MafA的转录,MafA反过来调节Glis3的表达.
结论:
- 在慢性高血糖症下降的Glis3表达有助于降低胰岛素转录和β细胞功能障碍.
- 通过与MafA和染色体重塑的复杂调节相互作用,Glis3在维护β细胞身份和功能方面发挥着关键作用.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Hormones Regulating Blood Glucose
3.3K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.3K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Insulin Secretory Vesicles
4.9K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
4.9K
Glucagon-like Receptor Agonists
319
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
319
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K

